These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 3886756)
41. The treatment of congestive heart failure. Digitalis glycosides are still the primary mode of therapy. Tobin JR Arch Intern Med; 1978 Mar; 138(3):453-4. PubMed ID: 629640 [No Abstract] [Full Text] [Related]
42. [Effects of cardiac glycosides and aglycones on the sufficient heart]. Bussmann WD; Wirz P; Lüthy E; Krayenbühl HP Dtsch Med Wochenschr; 1969 Apr; 94(15):779-85. PubMed ID: 5777261 [No Abstract] [Full Text] [Related]
43. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Ferguson DW; Abboud FM; Mark AL Circulation; 1984 Mar; 69(3):451-60. PubMed ID: 6692507 [TBL] [Abstract][Full Text] [Related]
44. Digitalis in cardiac failure. Do benefits justify risks? Selzer A Arch Intern Med; 1981 Jan; 141(1):18-9. PubMed ID: 7447579 [No Abstract] [Full Text] [Related]
45. The central nervous system as a site of action for the coronary vasoconstrictor effect of digoxin. Garan H; Smith TW; Powell WJ J Clin Invest; 1974 Dec; 54(6):1365-72. PubMed ID: 4436438 [TBL] [Abstract][Full Text] [Related]
46. [Biochemistry and clinical aspects of digitalis]. Repke K Internist (Berl); 1966 Aug; 7(8):418-26. PubMed ID: 4863415 [No Abstract] [Full Text] [Related]
47. Similarity and dissimilarity of the vasoconstrictor effects of Bay K 8644 on coronary, femoral, mesenteric and renal circulations of dogs. Ishii K; Sato Y; Taira N Br J Pharmacol; 1986 Jun; 88(2):369-77. PubMed ID: 2425879 [TBL] [Abstract][Full Text] [Related]
48. Sympathetic dysregulation in heart failure: mechanisms and therapy. Mark AL Clin Cardiol; 1995 Mar; 18(3 Suppl I):I3-8. PubMed ID: 7743696 [TBL] [Abstract][Full Text] [Related]
49. Cardiocirculatory dynamics in the normal and failing heart. Zelis R; Flaim SF; Liedtke AJ; Nellis SH Annu Rev Physiol; 1981; 43():455-76. PubMed ID: 6452090 [TBL] [Abstract][Full Text] [Related]
50. STUDIES ON THE CARDIOCIRCULATORY ACTIONS OF DIGITALIS. BRAUNWALD E; MASON DT; ROSS J Medicine (Baltimore); 1965 May; 44():233-48. PubMed ID: 14315275 [No Abstract] [Full Text] [Related]
51. Effect of digitalis on norepinephrine kinetics in congestive heart failure. Goldsmith SR; Simon AB; Miller E J Am Coll Cardiol; 1992 Oct; 20(4):858-63. PubMed ID: 1527296 [TBL] [Abstract][Full Text] [Related]
53. The role of the nervous system in the cardiovascular effects of digitalis. Gillis RA; Quest JA Pharmacol Rev; 1979 Mar; 31(1):19-97. PubMed ID: 43983 [No Abstract] [Full Text] [Related]
54. Effects and mechanism of action of aminophylline on cardiac function and regional blood flow distribution in conscious dogs. Rutherford JD; Vatner SF; Braunwald E Circulation; 1981 Feb; 63(2):378-87. PubMed ID: 6108802 [TBL] [Abstract][Full Text] [Related]
55. Influence of norepinephrine and digitalis on myocardial oxygen consumption in the newborn lamb. Downing SE; Lee JC; Taylor JF; Halloran K Circ Res; 1973 Apr; 32(4):471-9. PubMed ID: 4702041 [No Abstract] [Full Text] [Related]
56. Effect of ouabain on total vascular capacity in the dog. Goldman MR; Wolk SW; Rutlen DL; Powell WJ J Clin Invest; 1982 Jan; 69(1):175-84. PubMed ID: 7054237 [TBL] [Abstract][Full Text] [Related]
57. Neural actions of digitalis. Gillis RA; Quest JA Annu Rev Med; 1978; 29():73-9. PubMed ID: 348050 [No Abstract] [Full Text] [Related]
58. Pharmacology in critical care. Digitalis toxicity and treatment with phenytoin: a neurologic mechanism of action. Moore SJ Heart Lung; 1977; 6(6):1035-40. PubMed ID: 244318 [No Abstract] [Full Text] [Related]